Prothena Corp Public (PRTA) Non-Current Deffered Revenue (2012 - 2025)

Prothena Corp Public's (PRTA) quarterly Non-Current Deffered Revenue came in at $1.6 million in Q1 2025, down 97.59% year-on-year from $67.4 million in Q1 2024, and down 52.96% quarter-over-quarter from $3.4 million in Q4 2024.

Prothena Corp Public (PRTA) Non-Current Deffered Revenue (2012 - 2025) Analysis & Trends

Prothena Corp Public's Non-Current Deffered Revenue history runs 14 years deep, the most recent figure standing at $1.6 million for Q1 2025.

  • On a quarterly basis, Non-Current Deffered Revenue fell 97.59% year-over-year to $1.6 million in Q1 2025; TTM through Mar 2025 was $1.6 million, a 97.59% decrease from a year earlier, with the FY2024 full-year figure at $3.4 million, down 94.88% from the prior year.
  • Non-Current Deffered Revenue fell to $1.6 million in Q1 2025 per PRTA's latest filing, from $3.4 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $110.2 million in Q1 2021 and bottomed at $1.6 million in Q1 2025.
  • The 5-year median for Non-Current Deffered Revenue is $85.3 million (2021), against an average of $68.1 million.
  • Across the five-year window, Non-Current Deffered Revenue grew 15.31% in 2022 and plunged 97.59% in 2025, its largest moves.
  • Year by year, Non-Current Deffered Revenue stood at $102.9 million in 2021, then slipped by 17.14% to $85.3 million in 2022, then retreated by 20.97% to $67.4 million in 2023, then slumped by 94.88% to $3.4 million in 2024, then slumped by 52.96% to $1.6 million in 2025.
  • Per Business Quant, the three latest PRTA Non-Current Deffered Revenue figures stand at $1.6 million (Q1 2025), $3.4 million (Q4 2024), and $5.6 million (Q3 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 225.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Prothena Corp Public 458.13 Mn 128.67 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 1.62 Mn
Dec 31, 2024 3.45 Mn
Sep 30, 2024 5.60 Mn
Jun 30, 2024 7.37 Mn
Mar 31, 2024 67.41 Mn
Dec 31, 2023 67.41 Mn
Sep 30, 2023 67.41 Mn
Jun 30, 2023 67.41 Mn
Mar 31, 2023 85.29 Mn
Dec 31, 2022 85.29 Mn
Sep 30, 2022 96.99 Mn
Jun 30, 2022 98.35 Mn
Mar 31, 2022 100.64 Mn
Dec 31, 2021 102.93 Mn
Sep 30, 2021 104.56 Mn
Jun 30, 2021 85.29 Mn
Mar 31, 2021 110.24 Mn
Dec 31, 2020 110.24 Mn
Sep 30, 2020 110.24 Mn
Jun 30, 2020 110.24 Mn